Literature DB >> 15358780

Zinc potentiates an uncoupled anion conductance associated with the dopamine transporter.

Anne-Kristine Meinild1, Harald H Sitte, Ulrik Gether.   

Abstract

Binding of Zn(2+) to an endogenous binding site in the dopamine transporter (DAT) leads to inhibition of dopamine (DA) uptake and enhancement of carrier-mediated substrate efflux. To elucidate the molecular mechanism for this dual effect, we expressed the DAT and selected mutants in Xenopus laevis oocytes and applied the two-electrode voltage clamp technique together with substrate flux studies employing radiolabeled tracers. Under voltage clamp conditions we found that Zn(2+) (10 mum) enhanced the current induced by both DA and amphetamine. This was not accompanied by a change in the uptake rate but by a marked increase in the charge/DA flux coupling ratio as assessed from concomitant measurements of [(3)H]DA uptake and currents in voltage-clamped oocytes. These data suggest that Zn(2+) facilitates an uncoupled ion conductance mediated by DAT. Whereas this required substrate in the wild type (WT), we observed that Zn(2+) by itself activated such a conductance in a previously described mutant (Y335A). This signifies that the conductance is not strictly dependent on an active transport process. Ion substitution experiments in Y335A, as well as in WT, indicated that the uncoupled conductance activated by Zn(2+) was mainly carried by Cl(-). Experiments in oocytes under non-voltage-clamped conditions revealed furthermore that Zn(2+) could enhance the depolarizing effect of substrates in oocytes expressing WT. The data suggest that by potentiating an uncoupled Cl(-) conductance, Zn(2+) is capable of modulating the membrane potential of cells expressing DAT and as a result cause simultaneous inhibition of uptake and enhancement of efflux.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358780     DOI: 10.1074/jbc.M407660200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  The second sodium site in the dopamine transporter controls cation permeation and is regulated by chloride.

Authors:  Lars Borre; Thorvald F Andreassen; Lei Shi; Harel Weinstein; Ulrik Gether
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

2.  An N-terminal threonine mutation produces an efflux-favorable, sodium-primed conformation of the human dopamine transporter.

Authors:  Rheaclare Fraser; Yongyue Chen; Bipasha Guptaroy; Kathryn D Luderman; Stephanie L Stokes; Asim Beg; Louis J DeFelice; Margaret E Gnegy
Journal:  Mol Pharmacol       Date:  2014-04-21       Impact factor: 4.436

3.  Molecular Mechanism of Dopamine Transport by Human Dopamine Transporter.

Authors:  Mary Hongying Cheng; Ivet Bahar
Journal:  Structure       Date:  2015-10-15       Impact factor: 5.006

4.  How do glutamate transporters function as transporters and ion channels?

Authors:  Christof Grewer; Armanda Gameiro
Journal:  Biophys J       Date:  2014-08-05       Impact factor: 4.033

5.  Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes.

Authors:  Freja Herborg; Thorvald F Andreassen; Frida Berlin; Claus J Loland; Ulrik Gether
Journal:  J Biol Chem       Date:  2018-03-20       Impact factor: 5.157

6.  The N terminus of monoamine transporters is a lever required for the action of amphetamines.

Authors:  Sonja Sucic; Stefan Dallinger; Barbara Zdrazil; René Weissensteiner; Trine N Jørgensen; Marion Holy; Oliver Kudlacek; Stefan Seidel; Joo Hwan Cha; Ulrik Gether; Amy H Newman; Gerhard F Ecker; Michael Freissmuth; Harald H Sitte
Journal:  J Biol Chem       Date:  2010-01-29       Impact factor: 5.157

7.  The two Na+ sites in the human serotonin transporter play distinct roles in the ion coupling and electrogenicity of transport.

Authors:  Bruce Felts; Akula Bala Pramod; Walter Sandtner; Nathan Burbach; Simon Bulling; Harald H Sitte; L Keith Henry
Journal:  J Biol Chem       Date:  2013-11-29       Impact factor: 5.157

8.  Direct effects of manganese compounds on dopamine and its metabolite Dopac: an in vitro study.

Authors:  Shannon C Sistrunk; Matthew K Ross; Nikolay M Filipov
Journal:  Environ Toxicol Pharmacol       Date:  2007-05       Impact factor: 4.860

Review 9.  The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango.

Authors:  Harald H Sitte; Michael Freissmuth
Journal:  J Neurochem       Date:  2009-11-05       Impact factor: 5.372

10.  Antagonist-induced conformational changes in dopamine transporter extracellular loop two involve residues in a potential salt bridge.

Authors:  Jon D Gaffaney; Madhur Shetty; Bruce Felts; Akula-Bala Pramod; James D Foster; L Keith Henry; Roxanne A Vaughan
Journal:  Neurochem Int       Date:  2013-11-20       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.